Morphine Sulfate 3 mg/ in 0 recalled over sterility concerns
- Recall date
- December 17, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- SCA Pharmaceuticals recalls Morphine Sulfate 3 mg/3 mL in 0.9% Sodium Chloride (1mg/mL) CII, Rx Only, 3 ml Single Dose Syringe, SCA Pharmaceuticals…
- Recall number
- D-0201-2021
- FDA classification
- Class III
- Brand / firm
- SCA Pharmaceuticals
- Sold / distributed
- Product was distributed to hospitals nationwide.
Why it was recalled
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Morphine Sulfate 3 mg/3 mL in 0.9% Sodium Chloride (1mg/mL) CII, Rx Only, 3 ml Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010025
Get recall alerts
Free email alert whenever SCA Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: SCA Pharmaceuticals